Bionaut Labs

Los Angeles, United States Founded: 2015 • Age: 11 yrs
Miniature robots are developed for targeted drug delivery applications.

About Bionaut Labs

Bionaut Labs is a company based in Los Angeles (United States) founded in 2015 by Alex Shpunt and Michael Shpigelmacher. Bionaut Labs has raised $63.2 million across 2 funding rounds from investors including OurCrowd, Khosla Ventures and GISEV. Bionaut Labs offers products and services including Bionauts. Bionaut Labs operates in a competitive market with competitors including 10X Genomics, Mission Bio, Singleron, Liquidia and Sirnaomics, among others.

  • Headquarter Los Angeles, United States
  • Founders Alex Shpunt, Michael Shpigelmacher
  • Sectors
    Healthcare
  • Website bionautlabs.com
  • Social LinkedIn X
  • Legal Name Bionaut Labs Inc
Key Metrics
  • Total Equity Funding
    $63.2M (USD)

    in 2 rounds

  • Latest Funding Round
    $43.2M (USD), Series B

    Nov 2022

  • Investors
    OurCrowd

    & 13 more

Products & Services of Bionaut Labs

Bionaut Labs offers a comprehensive portfolio of products and services, including Bionauts.

Bionauts
Medical Device

Micro-robots for targeted drug delivery and body diagnostics.

Funding Insights of Bionaut Labs

Bionaut Labs has successfully raised a total of $63.2M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $43.2 million completed in November 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $63.2M
  • Total Rounds 2
  • Last Round Series B β€” $43.2M
  • First Round $20M

    (Mar 2021)

  • Investors Count 14

All 2 funding rounds of Bionaut Labs with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Nov 2022$43.2MSeries B–Khosla Ventures
Mar 2021$20MSeries A–Khosla Ventures
Valuation history

14 investors in total: 13 institutional and 1 angel.

Investors in Bionaut Labs

Bionaut Labs has secured backing from 14 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include OurCrowd, Khosla Ventures and GISEV.

All
Venture Fund
Institutional
Angel
InvestorDescriptionFounded YearDomainLocation
Early-stage startups are funded by this venture capital firm.
2004khoslaventures.comMenlo Park, United States
Venture capital fund focused on tech startups
–sixtydegreecapital.comNorth York, Canada
Venture capital fund focused on early-stage biotech, life sciences, IT, and multiple sectors
–dolbyventures.comSan Francisco, United States
Investments in healthcare startups are made by What If Ventures.
–whatif.vcFrisco, United States
Venture capital investing with a focus on diversity and inclusion in the ecosystem.
–gaingels.com-
Venture capital funding is provided to early-stage companies.
–upfront.comLos Angeles, United States
Early-stage life sciences and tech focused VC firm investing primarily in the US
–boldcapitalpartners.comSanta Monica, United States
Revolution is recognized as a D.C.-based investment firm.
–revolution.comWashington, Dc, United States
Compound is recognized as a thesis-driven investment firm.
–compound.vcNew York, United States
-
–deepinsight.co.il-
Premium access

Investor details for Bionaut Labs

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Bionaut Labs

37 people are tracked at Bionaut Labs (6 in leadership, 22 in board & advisors, 9 in team).

NameRoleGroup
Alex Shpunt
Co-FounderLeadership
Michael Shpigelmacher
Co-Founder & CEOLeadership
Florent Cros
Vp, Advanced ResearchLeadership
Daniel Geffken
Interim Chief Financial OfficerLeadership
Eran Oren
Chief Technology OfficerLeadership
Bahar Sutorius
Vice President Of DevelopmentLeadership
Susan Alpert
Senior Regulatory AdvisorBoard & advisors
Aviad Maizels
Executive Chairman & FounderBoard & advisors
Anita Gupta
Pain Management & Anesthesiology AdvisorBoard & advisors
Marlene E Haffner
Senior Regulatory AdvisorBoard & advisors
Chetan Bettegowda
Neurosurgery AdvisorBoard & advisors
Kevin Zhang
DirectorBoard & advisors
Errol De Souza
Independent Board MemberBoard & advisors
John Crawford
Neurology AdvisorBoard & advisors
Gary Schwartz
Senior Medical AdvisorBoard & advisors
Santosh Kesari
Neurology AdvisorBoard & advisors
Jay D Kranzler
Senior Medical AdvisorBoard & advisors
Ehsan Saadat
Spinal Surgery AdvisorBoard & advisors
Houman David Hemmati
Ophthalmology AdvisorBoard & advisors
Peer Fischer
Senior Scientific AdvisorBoard & advisors

17 more people are available in the full profile.

Premium access

Complete people profiles for Bionaut Labs

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Bionaut Labs

3 dated milestones of Bionaut Labs across 7 years, from founding to its latest funding, stage changes and deals.

  1. Founded Bionaut Labs is founded.
  2. Funding First funding round of $20.0M.
  3. Funding Latest funding round, Series B, of $43.2M.

Competitors of Bionaut Labs

Bionaut Labs operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as 10X Genomics, Mission Bio, Singleron, Liquidia and Sirnaomics, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
10xgenomics.com2012Pleasanton, United States$199.9M961
Instrument systems for genomic research and sequencing libraries are developed.
missionbio.com2014San Francisco, United States$110M109
Single-cell multi-omics platform is provided for genotypic and phenotypic analysis.
singleron.bio2018Hagen, Germany$84.48M–
Developer of single-cell multi-omics platform for clinical research and molecular diagnosis
liquidia.com2004United States$75.3M63
Engineered particles & films for life and material sciences applications
sirnaomics.com2007Gaithersburg, United States$267M88
RNA-based therapeutics for cancer and fibrosis are developed.
cellares.com2019San Francisco, United States$355M–
Medical devices for cell-based therapy manufacturing are produced.
acorda.com1995Ardsley, United States$66.5M109
Engaged in the development and commercialization of therapies that improve neurological function.
lumicks.com2014Amsterdam, Netherlands$93.38M–
Optical tweezers instruments for single-molecule analysis are manufactured.
nanosyrinx.com2018Coventry, United Kingdom$21.63M17
Drug delivery systems to cell interiors are developed via nanosyringes.
Premium access

Detailed competitors of Bionaut Labs

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Bionaut Labs

The website of Bionaut Labs (bionautlabs.com) receives about 2.3K visits a month.

  • Monthly visits
    2.3K

    ▲ 20.7% vs previous month

Latest news on Bionaut Labs

Premium access

Complete news archive for Bionaut Labs

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Similar companies to Bionaut Labs

10 companies that operate in the same segment as Bionaut Labs (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
mRNA-based therapeutics for diseases including cancer and infections are developed.
2010Cambridge, Massachusetts, United StatesUSD 2.78 BUSD 1.94 B5,800
Digital sequencing technology for cancer detection is developed.
2012Redwood City, California, United StatesUSD 557.5 MUSD 982.02 M2,020
Circulating tumor DNA is screened for early cancer detection.
2016Menlo Park, California, United StatesUSD 3.22 BUSD 147.17 M1,000
Nanopore-based electronic systems for single-molecule analysis are developed.
2005Oxford, Oxfordshire, United KingdomUSD 1.3 BUSD 301.49 M1,480
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits
2006Sunnyvale, California, United StatesUSD 943.53 MUSD 189.9 M265
Provider of DNA testing services to create a family tree and ancestor
2003Yehud, Central District, IsraelUSD 40 M––
Genetically modified cell lines are developed using AAV gene-editing platform.
2007Cambridge, Cambridgeshire, United KingdomUSD 46.29 M––
Gene therapies for rare diseases including retinal dystrophies are developed.
2013Philadelphia, Pennsylvania, United StatesUSD 82.8 MUSD 64.73 M822
Therapeutics for genetic diseases are developed through targeted interventions.
2015Palo Alto, California, United StatesUSD 434.2 MUSD 502.08 M730
Provider of an online genealogy platform offering a host of services
1996Lehi, Utah, United StatesUSD 146.2 M––
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Bionaut Labs

Bionaut Labs was founded in 2015 and raised its 1st funding round 6 years after it was founded.

Bionaut Labs is headquartered in Los Angeles, United States. It is registered at Los Angeles, California, United States.

Michael Shpigelmacher is the current CEO of Bionaut Labs. They have also founded this company.

Bionaut Labs is a funded company, having raised a total of $63.2M across 2 funding rounds to date. The company's 1st funding round was a Series A of $20M, raised on Mar 2021.

Bionaut Labs was established in 2015 in Los Angeles, United States, within the biotechnology sector. Miniature robots are engineered for precise drug delivery to disease sites, supported by remote control and imaging systems. These tools facilitate treatments for brain disorders. Additional technologies are provided for gene therapy, CRISPR-Cas9 applications, and oncolytic viruses, aiding medical interventions.

Bionaut Labs's top competitors include 10X Genomics, Mission Bio and Sirnaomics.

Bionaut Labs offers Bionauts.

Bionaut Labs has 14 investors. Key investors include OurCrowd, Khosla Ventures, GISEV, PSPRS, and Sixty Degree Capital.

Bionaut Labs operates through Bionaut Labs Inc.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available